The Enhanced Efficacy of Intracellular Delivery of Doxorubicin/C6-Ceramide Combination Mediated by the F3 Peptide/Nucleolin System Is Supported by the Downregulation of the Pi3K/Akt Pathway
AuthID
P-00V-4AC
P-00V-4AC